Yasuo Urata
Founder at ONCOLYS BIOPHARMA INC.
Net worth: 3 M $ as of 2024-03-30
Profile
Yasuo Urata is the founder of Oncolys BioPharma, Inc. which was founded in 2004.
He is currently the Chairman of Oncolys USA, Inc. since 2016.
Mr. Urata was an Outside Director at Tacere Therapeutics, Inc. in 2011 and an Independent Director at WONIK CUBE Corp.
He worked as a Principal at Japan Tobacco, Inc. from 1994 to 2004 and at Ono Pharmaceutical Co., Ltd.
Mr. Urata graduated from Kyoto Pharmaceutical University with a graduate degree in 1983 and from Tokai High School with an undergraduate degree in 1974.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ONCOLYS BIOPHARMA, INC.
2.45% | 2022-12-30 | 496,900 ( 2.45% ) | 3 M $ | 2024-03-30 |
Yasuo Urata active positions
Companies | Position | Start |
---|---|---|
ONCOLYS BIOPHARMA INC. | Founder | 2004-03-17 |
Oncolys USA, Inc. | Chairman | 2016-07-31 |
Former positions of Yasuo Urata
Companies | Position | End |
---|---|---|
JAPAN TOBACCO, INC. | Corporate Officer/Principal | - |
ONO PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
WONIK CUBE CORP. | Director/Board Member | - |
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Director/Board Member | - |
Training of Yasuo Urata
Kyoto Pharmaceutical University | Graduate Degree |
Tokai High School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
JAPAN TOBACCO, INC. | Consumer Non-Durables |
ONO PHARMACEUTICAL CO., LTD. | Health Technology |
WONIK CUBE CORP. | Distribution Services |
ONCOLYS BIOPHARMA INC. | Health Technology |
Private companies | 2 |
---|---|
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Health Technology |
Oncolys USA, Inc. |
- Stock Market
- Insiders
- Yasuo Urata